EverQuote (EVER)
(Delayed Data from NSDQ)
$24.83 USD
-1.06 (-4.08%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $24.76 -0.07 (-0.26%) 7:58 PM ET
2-Buy of 5 2
F Value A Growth C Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$24.83 USD
-1.06 (-4.08%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $24.76 -0.07 (-0.26%) 7:58 PM ET
2-Buy of 5 2
F Value A Growth C Momentum B VGM
Zacks News
What's in the Cards for Everest Re (RE) in Q3 Earnings?
by Zacks Equity Research
Everest Re's (RE) Q3 results are likely to benefit from increases across all lines of business, strong renewal retention and growth in international operations, offset by higher cat loss.
Down 18.2% in 4 Weeks, Here's Why You Should You Buy the Dip in EverQuote (EVER)
by Zacks Equity Research
The heavy selling pressure might have exhausted for EverQuote (EVER) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Chubb's (CB) Q3 Earnings Coming Up: What's in the Cards?
by Zacks Equity Research
Chubb's (CB) Q3 earnings are likely to reflect higher premiums and improved net investment income, offset by higher expenses.
W.R. Berkley (WRB) to Report Q3 Earnings: What's in the Offing?
by Zacks Equity Research
Higher premium growth, increased net investment income and an improved expense ratio are likely to have aided W.R. Berkley's (WRB) third-quarter performance. The results are likely to be partly offset by higher expenses.
Why Should You Hold Assurant (AIZ) Stock in Your Portfolio?
by Zacks Equity Research
Higher trade-in volumes, international earnings, and income from fixed maturity securities, and a solid capital management policy continue to drive Assurant (AIZ).
Nasdaq (NDAQ) to Report Q3 Earnings: What's in the Offing?
by Zacks Equity Research
Solid organic revenue growth, strong performance at index and analytics businesses and contributions from the acquisition of Verafin are likely to have aided Nasdaq's third-quarter performance.
EverQuote (EVER) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
by Zacks Equity Research
After losing some value lately, a hammer chart pattern has been formed for EverQuote (EVER), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
What's in the Cards for Travelers (TRV) in Q3 Earnings?
by Zacks Equity Research
Travelers' (TRV) third-quarter results are likely to reflect new business premiums, strong retention rates, better pricing, partly offset by higher expenses.
Reasons Why EverQuote (EVER) Stock is an Attractive Pick
by Zacks Equity Research
EverQuote (EVER) is poised to benefit from inorganic growth, solid performance of automotive insurance providers and financial flexibility.
Progressive (PGR) to Release Q3 Earnings: Is a Beat in Store?
by Zacks Equity Research
Progressive's (PGR) Q3 earnings are likely to reflect improved rates, solid policies in force and higher retention in its strong Vehicle and Property businesses.
EverQuote (EVER) Down 11.1% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
EverQuote (EVER) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Should You Retain EverQuote (EVER) Stock in Your Portfolio?
by Zacks Equity Research
EverQuote (EVER) is poised to benefit from inorganic growth, growth in commissions revenue and financial flexibility.
Allstate (ALL) Q2 Earnings Beat on Higher Premiums, Costs Ail
by Zacks Equity Research
Allstate (ALL) has $1.8 billion left under its share buyback authorization.
MetLife (MET) Q2 Earnings Beat on Strong Latin America Unit
by Zacks Equity Research
MetLife's (MET) adjusted net investment income declines on reduced variable investment income, stemming from decreased private equity returns.
Can EverQuote (EVER) Climb 42% to Reach the Level Wall Street Analysts Expect?
by Zacks Equity Research
The consensus price target hints at a 42.4% upside potential for EverQuote (EVER). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
EverQuote (EVER) Q2 Loss Narrower Than Expected, View Tweaked
by Zacks Equity Research
EverQuote's (EVER) Q2 results witnessed lower revenues from Automotive insurance but higher revenues in the Other insurance vertical. Expenses decreased.
EverQuote (EVER) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
EverQuote (EVER) delivered earnings and revenue surprises of 74.47% and 7.15%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Reasons Why Investors Should Retain EverQuote (EVER) Stock Now
by Zacks Equity Research
EverQuote (EVER) is poised to benefit from higher quote requests, the solid performance of automotive insurance providers and financial flexibility.
Should You Retain EverQuote (EVER) Stock in Your Portfolio?
by Zacks Equity Research
EverQuote (EVER) is poised to benefit from higher quote requests, solid performance of automotive insurance providers and sufficient liquidity.
Why Is EverQuote (EVER) Down 26.4% Since Last Earnings Report?
by Zacks Equity Research
EverQuote (EVER) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Prudential (PRU) Q1 Earnings Beat, Fall Y/Y, Dividend Up (Revised)
by Zacks Equity Research
Prudential's (PRU) Q1 results reflect higher contributions from U.S. Businesses, partially offset by poor performance of PGIM and International businesses.
Assurant (AIZ) Q1 Earnings Beat Estimates, Increase Y/Y (Revised)
by Zacks Equity Research
Assurant's (AIZ) Q1 results reflect higher net investment income and lower catastrophes losses, offset by higher expenses.
Prudential (PRU) Q1 Earnings Beat, Fall Y/Y, Dividend Up
by Zacks Equity Research
Prudential's (PRU) Q1 results reflect higher contributions from U.S. Businesses, partially offset by poor performance of PGIM and International businesses.
Assurant (AIZ) Q1 Earnings Beat Estimates, Increase Y/Y
by Zacks Equity Research
Assurant's (AIZ) Q1 results reflect higher net investment income and lower catastrophes losses, offset by higher expenses.
EverQuote (EVER) Q1 Loss Lower Than Expected, Revenues Up Y/Y
by Zacks Equity Research
EverQuote's (EVER) 1Q results reflect higher revenues from Automotive insurance and Other insurance verticals in the reported quarter, partially offset by higher expenses.